Crossmark

Cost-effectiveness analysis of a randomized study of depression treatment options in primary care suggests stepped-care treatment may have economic benefits

Crossref DOI link: https://doi.org/10.1186/s12888-019-2223-3

Published Online: 2019-08-05

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yan, Charles https://orcid.org/0000-0002-7275-9345
Rittenbach, Katherine

Souri, Sepideh

Silverstone, Peter H.
Funding

Funding for this research was provided by:

Alberta Health Services
License Information

Text and Data Mining valid from 2019-08-05

Version of Record valid from 2019-08-05
More Information

Article History

Received: 7 September 2018

Accepted: 29 July 2019

First Online: 5 August 2019

Ethics approval and consent to participate

: The clinical trial reported in the analysis has received written consent from the Health Research Ethics Review Board at the University of Alberta (Pro00038495) for adults aged 18 who were cognitively capable of giving informed consent. Approval was first given on 30th July 2013 and then included some small changes.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below